Clinical Trial Update: Naloxone Nasal Spray Pharmacokinetic Study [Phase 1]

View source ↗

Summary

This document reports a Phase 1 pharmacokinetic study of naloxone nasal spray sponsored by Mitovie Pharma Ltd for opioid overdose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• Naloxone nasal spray (naloxone nasal spray)

Snippet

Sponsor: Mitovie Pharma Ltd | Conditions: Opioid Overdose | Phase 1 | Status: UNKNOWN